Full name
APIPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
20.13.Z - Manufacture of other inorganic basic chemicals
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.18.Z - Agents specialised in the sale of other particular products
46.19.Z - Agents involved in the sale of a variety of goods
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
64.92.Z - Other credit granting
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 191,1 | 290,2 | 330,5 | 13,9 |
EBITDA | 191,3 | 297 | 330,7 | 11,4 |
Short time liabilities | 17 | 25,9 | 74,9 | 188,9 |
Equity capital | 301 | 398,5 | 726,7 | 82,4 |
Operating profit (EBIT) | 191,3 | 290,1 | 330,7 | 14 |
Assets | 318 | 424,4 | 801,6 | 88,9 |
Net profit (loss) | 191,1 | 290,2 | 328,2 | 13,1 |
Cash | 296,7 | 17,5 | 582,4 | 3232,2 |
Net income from sale | 343,7 | 363,7 | 702,5 | 93,1 |
Liabilities and provisions for liabilities | 17 | 25,9 | 74,9 | 188,9 |
Working assets | 318 | 424,4 | 801,6 | 88,9 |
Depreciation | 0 | 6,9 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 63,5 | 72,8 | 45,2 | -27,6 |
Equity capital to total assets | 94,7 | 93,9 | 90,7 | -3,2 |
Gross profit margin | 55,6 | 79,8 | 47 | -32,8 |
EBITDA Margin | 55,6 | 81,7 | 47,1 | -34,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 26 | 39 | 13 |
Current financial liquidity indicator | 18.708707809448242 | 16.365169525146484 | 10.7001314163208 | -5,7 |
Net dept to EBITDA | -1.5328980684280396 | -0.047066811472177505 | -1.7505325078964233 | -1,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane